本研究以问卷调查的形式对101家医药企业展开调研,旨在评估《支持创新药高质量发展的若干措施》的政策认知度、实施预期以及推进过程中存在的障碍。研究结果显示,该政策对创新药研发的促进作用较为显著,30.69%的受访企业认为对创新药上市速度支持显著加快,37.62%的受访企业认为对市场推广非常有利,但仍存在一些需要提升的地方,如医保数据开放程度不足,企业对创新药多元支付能力现状的评价总体偏低,目录准入流程有待进一步优化,临床使用环节受限等。建议政府构建以临床价值为导向的全链条政策生态,通过细化创新分级与定价规则、强化协同,破除医疗机构使用壁垒,医药企业聚焦价值调整策略,商业保险公司等构建多元支付与产业生态等举措,构建更为完善的创新药全链条支持体系,推动《支持创新药高质量发展的若干措施》更好落地生效,将政策优势转化为产业高质量发展动能。

This study conducted a questionnaire survey among 101 pharmaceutical enterprises to evaluate the policy awareness, implementation expectations, and obstacles encountered during the promotion of "Several Measures to Support the High-Quality Development of Innovative Drugs". The results indicate that the policy has a relatively significant promotional effect on innovative drug R&D. 30.69% of enterprises believed it significantly accelerated the market approval speed for innovative drugs, and 37.62% considered it highly favorable for market promotion. However, there is still room for improvement, including insufficient openness of healthcare insurance data, an overall low evaluation by enterprises regarding the current state of multi-channel payment capabilities for innovative drugs, a need for further optimization of the reimbursement list inclusion process, and limitations in clinical application. This study recommends that the government constructs a clinical value-oriented, full-chain policy ecosystem. Through measures such as refining innovation grading and pricing rules, strengthening multi-departmental coordination, eliminating barriers to drug use in medical institutions, guiding pharmaceutical enterprises to adjust their strategies focusing on value, and encouraging commercial insurance companies to build multi-payment and industry-supporting ecosystems, a more comprehensive full-chain support system for innovative drugs can be established. This will facilitate the better implementation and effectiveness of "Several Measures to Support the High-Quality Development of Innovative Drugs", transforming policy advantages into momentum for the high-quality development of the industry.